Chong, B, Kong, G, Shankar, K, Chew, HSJ, Lin, C, Goh, R, Chin, YH, Tan, DJH, Chan, KE, Lim, WH, Syn, N, Chan, SP, Wang, J-W, Khoo, CM, Dimitriadis, GK, Wijarnpreecha, K, Sanyal, A, Noureddin, M, Siddiqui, MS, Foo, R, Mehta, A, Figtree, GA, Hausenloy, DJ, Chan, MY, Ng, CH, Muthiah, M, Mamas, MA and Chew, NWS (2023) The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019. Metabolism. 155402 - 155402. ISSN 0026-0495

[thumbnail of METABOLISM-D-22-01813_R2.pdf] Text
METABOLISM-D-22-01813_R2.pdf - Accepted Version
Restricted to Repository staff only until 27 January 2024.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (8MB)


Background: A significant proportion of premature deaths globally are related to metabolic diseases in young adults. We examined the global trends and mortality of metabolic diseases in individuals aged below 40 years using data from the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) 2019.

Methods: From 2000-2019, global estimates of deaths and disability-adjusted life years (DALYs) were described for metabolic diseases (type 2 diabetes mellitus [T2DM], hyperlipidemia, hypertension, obesity, non-alcoholic fatty liver disease [NAFLD]). Subgroup analyses were performed based on sex, geographical regions and Socio-Demographic Index (SDI). Age-standardised death and DALYs were presented per 100,000 population with 95% uncertainty intervals (UI). Projections of mortality and DALYs were estimated using regression models based on the GBD 2019 data and combining them with Institute for Health Metrics and Evaluation projection counts for years up to 2050.

Results: In 2019, the highest age-standardised death rates were observed in hypertension (133·88 [121·25-155·73]), followed by obesity (62·59 [39·92-89·13]), hyperlipidemia (56·51 [41·83-73·62]), T2DM (18·49 [17·18-19·66]) and NAFLD (2·09 [1·61-2·60]). Similarly, obesity (1932·54 [1276·61-2639·74]) had the highest age-standardised DALYs, followed by hypertension (2885·57 [2580·75-3201·05]), hyperlipidemia (1207·15 [975·07-1461·11]), T2DM (801·55 [670·58-954·43]) and NAFLD (53·33 [40·73-68·29]). Mortality rates decreased over time in hyperlipidemia (-0·6%), hypertension (-0·47%), NAFLD (-0·31%) and T2DM (-0·20%), but not in obesity (1·07% increase). The highest metabolic-related mortality was observed in Eastern Mediterranean and low SDI countries. By 2050, obesity is projected to contribute to the largest number of deaths (102·8% increase from 2019), followed by hypertension (61·4% increase), hyperlipidemia (60·8% increase), T2DM (158·6% increase) and NAFLD (158·4% increase), with males continuing to bear the greatest burden across all metabolic diseases.

Item Type: Article
Additional Information: The final version of this article and all relevant information related to it, including copyrights, can be found on the publisher website.
Subjects: R Medicine > R Medicine (General)
R Medicine > R Medicine (General) > R735 Medical education. Medical schools. Research
R Medicine > RA Public aspects of medicine
Divisions: Faculty of Medicine and Health Sciences > School of Medicine
Related URLs:
Depositing User: Symplectic
Date Deposited: 07 Feb 2023 13:40
Last Modified: 07 Feb 2023 13:40

Actions (login required)

View Item
View Item